Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary Shares, $0.01 par value per share
-
Shares outstanding
-
29M
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
1.17M
-
Shares change
-
-870K
-
Total reported value, excl. options
-
$2.07M
-
Value change
-
-$600K
-
Number of buys
-
12
-
Number of sells
-
-6
-
Price
-
$1.77
Significant Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q4 2024
24 filings reported holding ITRM - Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share as of Q4 2024.
Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.17M shares
of 29M outstanding shares and own 4.04% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (439K shares), New Leaf Venture Partners, L.L.C. (345K shares), Apollon Financial, LLC (250K shares), TWO SIGMA INVESTMENTS, LP (25.2K shares), CITADEL ADVISORS LLC (21.2K shares), Sanctuary Advisors, LLC (20K shares), Lee Financial Co (16K shares), Alpine Global Management, LLC (15K shares), GEODE CAPITAL MANAGEMENT, LLC (12.4K shares), and MORGAN STANLEY (11.7K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.